SymlinActive Ingredient(s): Pramlintide
FDA Approved: * March 16, 2005
Pharm Company: * AMYLIN
Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt. Contents 1 Pharmacology 2 Approval 3 Design and structure 4 References 5 External links Pharmacology Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the β cells of the pancreas along ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
to lower blood sugar...
cost of Symlin
Symlin (pramlintide acetate) injection 0.6mg/ml. 5ml.VGial...
others taking symlin
I'd like to chat with others who are taking symlin along with insulin...